David Domzalski's Net Worth
$1.06 Million
Who is David Domzalski?
David Domzalski has an estimated net worth of $1.06 Million. This is based on reported shares across multiple companies, which include Foamix Pharmaceuticals Ltd., and VYNE Therapeutics Inc..
SEC CIK
David Domzalski's CIK is 0001727794
Past Insider Trading and Trends
2023 was David Domzalski's most active year for acquiring shares with 4 total transactions. David Domzalski's most active month to acquire stocks was the month of December. 2018 was David Domzalski's most active year for disposing of shares, totalling 13 transactions. David Domzalski's most active month to dispose stocks was the month of February. 2019 saw David Domzalski paying a total of $665,892.49 for 254,117 shares, this is the most they've acquired in one year. In 2018 David Domzalski cashed out on 49,150 shares for a total of $101,230.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Foamix Pharmaceuticals Ltd. No price found
CEODavid Domzalski used to own units in Ordinary Shares but no longer holds any shares there. From 2018 to 2020 David Domzalski acquired a total of 197,025 shares in Foamix Pharmaceuticals Ltd. at a cost of $33,846.52, David also disposed a total of 380,688 shares of Foamix Pharmaceuticals Ltd. equalling to $144,174.29.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -324.03K |
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +1.47% | 4.71K |
$2.68 | $12,597.64 | 324.03K |
Mar 2
| |||
Form 4
| +47.78% | 103.25K |
—
|
—
| 319.32K |
Feb 24
| |||
Form 4
| -1.26% | -2.75K |
$3.28 | -$9,023.28 | 216.07K |
Dec 31
| |||
Form 4
| +4.71% | 9.84K |
$2.16 | $21,248.88 | 218.83K |
Nov 29
| |||
Form 4
| -1.07% | -2.26K |
$3.07 | -$6,925.92 | 208.98K |
Sep 30
| |||
Form 4
| -1.56% | -3.35K |
$2.35 | -$7,884.25 | 211.24K |
Jul 1
| |||
Form 4
| -2.32% | -5.10K |
$3.75 | -$19,110.00 | 214.59K |
Apr 1
| |||
Form 4
| +50.05% | 73.28K |
—
|
—
| 219.69K |
Jan 1
| |||
Form 4
| -0.05% | -68.00 |
$4.05 | -$275.40 | 146.41K |
Dec 3
| |||
Form 4
| -3.32% | -5.04K |
$3.90 | -$19,640.40 | 146.48K |
Nov 19
| |||
Form 4
| -1.34% | -2.06K |
$4.58 | -$9,443.96 | 151.51K |
Nov 8
| |||
Form 4
| -0.39% | -601.00 |
$5.81 | -$3,491.81 | 153.57K |
Oct 1
| |||
Form 4
| -0.04% | -67.00 |
$5.67 | -$379.89 | 154.18K |
Sep 4
| |||
Form 4
| -5.07% | -8.24K |
$5.68 | -$46,791.84 | 154.24K |
Aug 8
| |||
Form 4
| -0.37% | -602.00 |
$5.10 | -$3,070.20 | 162.48K |
Jul 2
| |||
Form 4
| -0.04% | -67.00 |
$5.26 | -$352.42 | 163.08K |
Jun 1
| |||
Form 4
| -12.54% | -23.40K |
—
|
—
| 163.15K |
May 8
| |||
Form 4
| -0.43% | -602.00 |
$5.08 | -$3,058.16 | 139.75K |
Apr 2
| |||
Form 4
| -0.05% | -66.00 |
$5.95 | -$392.70 | 140.36K |
Mar 1
| |||
Form 4
| +2.59% | 3.55K |
$5.98 | -$14,334.06 | 140.42K |
Jan 1 - Jan 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
VYNE Therapeutics Inc. (VYNE) Snapshot price: $1.87
PRESIDENT AND CEODavid Domzalski owns 497,654 units of Common Stock which is worth $930,612.98. From 2020 to 2024 David Domzalski acquired a total of 506,071 shares in VYNE Therapeutics Inc. at a cost of $36,526.02, David also disposed a total of 47,258 shares of VYNE Therapeutics Inc. equalling to $60,502.88.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.19% | -935.00 |
$1.92 | -$1,795.20 | 497.65K |
Jul 1
| |||
Form 4
| +0.90% | 4.43K |
$2.16 | $9,562.21 | 498.59K |
May 31
| |||
Form 4
| -0.20% | -1.00K |
$3.08 | -$3,092.32 | 494.16K |
Apr 1
| |||
Form 4
| +82.60% | 224K |
$2.28 | -$2,289.12 | 495.16K |
Jan 1 - Jan 2
| |||
Form 4
| +487.35% | 225K |
—
|
—
| 271.17K |
Dec 13
| |||
Form 4
| +5.20% | 2.28K |
$2.81 | $6,426.03 | 46.17K |
Nov 30
| |||
Form 4
| -16.30% | -8.55K |
$3.83 | -$32,742.67 | 43.88K |
Oct 2
| |||
Form 4
| -1.84% | -981.00 |
$4.10 | -$4,022.10 | 52.43K |
Jun 30
| |||
Form 4
| +5.46% | 2.77K |
$3.46 | $9,560.13 | 53.41K |
May 31
| |||
Form 4
| -5.12% | -2.73K |
$3.08 | -$8,420.72 | 50.65K |
Mar 31
| |||
Form 4
| -0.99% | -10.69K |
$0.15 | -$1,602.75 | 1.06M |
Dec 31
| |||
Form 4
| +3.34% | 34.7K |
$0.20 | $6,861.18 | 1.07M |
Nov 30
| |||
Form 4
| -1.02% | -10.68K |
$0.22 | -$2,382.31 | 1.04M |
Sep 30
| |||
Form 4
| -1.01% | -10.68K |
$0.39 | -$4,155.69 | 1.05M |
Jun 30
| |||
Form 4
| +1.13% | 11.89K |
$0.35 | $4,116.47 | 1.06M |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||